{
  "trial_id": "NCT02630316",
  "trial_group": "hypertension",
  "generated-by-gpt4-omni-zs": {
    "gen-response": "Age, sex, race, body mass index (BMI), smoking status, baseline 6-minute walk distance (6MWD), pulmonary vascular resistance (PVR), pulmonary capillary wedge pressure (PCWP), mean pulmonary arterial pressure (mPAP), forced vital capacity (FVC), use of chronic medication for underlying lung disease, presence of connective tissue disease (CTD), oxygen supplementation requirement, left ventricular ejection fraction, history of drug abuse, presence of exacerbation of underlying lung disease, participation in pulmonary rehabilitation, use of investigational drug/device.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "sex"
        ],
        [
          "Race (NIH/OMB)",
          "race"
        ],
        [
          "BMI",
          "body mass index (BMI)"
        ],
        [
          "6 Minute Walk Distance",
          "baseline 6-minute walk distance (6MWD)"
        ],
        [
          "Pulmonary Vascular Resistance (PVR)",
          "pulmonary vascular resistance (PVR)"
        ],
        [
          "Mean pulmonary arterial pressure (PAPm)",
          "mean pulmonary arterial pressure (mPAP)"
        ],
        [
          "Pulmonary Capillary Wedge Pressure (PCWP)",
          "pulmonary capillary wedge pressure (PCWP)"
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Male",
        "Region of Enrollment",
        "Weight",
        "Height",
        "N-terminal prohormone brain natriuretic peptide (NT-proBNP)",
        "Vasodilator testing during confirmatory right heart catheterization (RHC)?",
        "10 mmHg decrease in PAPm during Confirmatory RHC?",
        "Vasodilator medications used during Confirmatory RHC?"
      ],
      "remaining_candidate_features": [
        "smoking status",
        "forced vital capacity (FVC)",
        "use of chronic medication for underlying lung disease",
        "presence of connective tissue disease (CTD)",
        "oxygen supplementation requirement",
        "left ventricular ejection fraction",
        "history of drug abuse",
        "presence of exacerbation of underlying lung disease",
        "participation in pulmonary rehabilitation",
        "use of investigational drug/device."
      ]
    },
    "processed-gen-response": "Age, sex, race, body mass index (BMI), smoking status, baseline 6-minute walk distance (6MWD), pulmonary vascular resistance (PVR), pulmonary capillary wedge pressure (PCWP), mean pulmonary arterial pressure (mPAP), forced vital capacity (FVC), use of chronic medication for underlying lung disease, presence of connective tissue disease (CTD), oxygen supplementation requirement, left ventricular ejection fraction, history of drug abuse, presence of exacerbation of underlying lung disease, participation in pulmonary rehabilitation, use of investigational drug/device."
  },
  "generated-by-gpt4-omni-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, Baseline 6-minute Walk Distance (6MWD), Pulmonary Vascular Resistance (PVR), Pulmonary Capillary Wedge Pressure (PCWP), Mean Pulmonary Arterial Pressure (mPAP), Forced Vital Capacity (FVC), Chronic Medication for Underlying Lung Disease,",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Race (NIH/OMB)",
          "Race/Ethnicity"
        ],
        [
          "Region of Enrollment",
          "Region of Enrollment"
        ],
        [
          "6 Minute Walk Distance",
          "Baseline 6-minute Walk Distance (6MWD)"
        ],
        [
          "Pulmonary Vascular Resistance (PVR)",
          "Pulmonary Vascular Resistance (PVR)"
        ],
        [
          "Pulmonary Capillary Wedge Pressure (PCWP)",
          "Pulmonary Capillary Wedge Pressure (PCWP)"
        ],
        [
          "Mean pulmonary arterial pressure (PAPm)",
          "Mean Pulmonary Arterial Pressure (mPAP)"
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Weight",
        "Height",
        "BMI",
        "N-terminal prohormone brain natriuretic peptide (NT-proBNP)",
        "Vasodilator testing during confirmatory right heart catheterization (RHC)?",
        "10 mmHg decrease in PAPm during Confirmatory RHC?",
        "Vasodilator medications used during Confirmatory RHC?"
      ],
      "remaining_candidate_features": [
        "Forced Vital Capacity (FVC)",
        "Chronic Medication for Underlying Lung Disease"
      ]
    },
    "processed-gen-response": "Age, Sex: Female, Male, Race/Ethnicity, Region of Enrollment, Baseline 6-minute Walk Distance (6MWD), Pulmonary Vascular Resistance (PVR), Pulmonary Capillary Wedge Pressure (PCWP), Mean Pulmonary Arterial Pressure (mPAP), Forced Vital Capacity (FVC), Chronic Medication for Underlying Lung Disease"
  },
  "generated-by-llama3-70b-in-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, Body Mass Index, Systolic Blood Pressure, Diastolic Blood Pressure, Pulmonary Vascular Resistance, Pulmonary Capillary Wedge Pressure, Mean Pulmonary Arterial Pressure, Six-Minute Walk Distance, Forced Vital Capacity, Diffusion Capacity of the Lungs for Carbon Monoxide, Oxygen Saturation, New York Heart Association Functional Class, World Health Organization Functional Class.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Race (NIH/OMB)",
          "Race/Ethnicity"
        ],
        [
          "Region of Enrollment",
          "Region of Enrollment"
        ],
        [
          "BMI",
          "Body Mass Index"
        ],
        [
          "Pulmonary Vascular Resistance (PVR)",
          "Pulmonary Vascular Resistance"
        ],
        [
          "Mean pulmonary arterial pressure (PAPm)",
          "Mean Pulmonary Arterial Pressure"
        ],
        [
          "Pulmonary Capillary Wedge Pressure (PCWP)",
          "Pulmonary Capillary Wedge Pressure"
        ],
        [
          "6 Minute Walk Distance",
          "Six-Minute Walk Distance"
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Weight",
        "Height",
        "N-terminal prohormone brain natriuretic peptide (NT-proBNP)",
        "Vasodilator testing during confirmatory right heart catheterization (RHC)?",
        "10 mmHg decrease in PAPm during Confirmatory RHC?",
        "Vasodilator medications used during Confirmatory RHC?"
      ],
      "remaining_candidate_features": [
        "Systolic Blood Pressure",
        "Diastolic Blood Pressure",
        "Forced Vital Capacity",
        "Diffusion Capacity of the Lungs for Carbon Monoxide",
        "Oxygen Saturation",
        "New York Heart Association Functional Class",
        "World Health Organization Functional Class."
      ]
    },
    "processed-gen-response": "Age, Sex: Female, Male, Race/Ethnicity, Region of Enrollment, Body Mass Index, Systolic Blood Pressure, Diastolic Blood Pressure, Pulmonary Vascular Resistance, Pulmonary Capillary Wedge Pressure, Mean Pulmonary Arterial Pressure, Six-Minute Walk Distance, Forced Vital Capacity, Diffusion Capacity of the Lungs for Carbon Monoxide, Oxygen Saturation, New York Heart Association Functional Class, World Health Organization Functional Class."
  },
  "generated-by-llama3-70b-in-zs": {
    "gen-response": "Age, sex, race, ethnicity, body mass index (BMI), smoking history, New York Heart Association (NYHA) functional class, 6-minute walk distance (6MWD) at baseline, forced vital capacity (FVC) at baseline, pulmonary vascular resistance (PVR) at baseline, pulmonary capillary wedge pressure (PCWP) at baseline, mean pulmonary arterial pressure (mPAP) at baseline, oxygen saturation at baseline, use of chronic medications for underlying lung disease, presence of connective tissue disease (CTD).",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "sex"
        ],
        [
          "Race (NIH/OMB)",
          "race"
        ],
        [
          "BMI",
          "body mass index (BMI)"
        ],
        [
          "6 Minute Walk Distance",
          "6-minute walk distance (6MWD) at baseline"
        ],
        [
          "Pulmonary Vascular Resistance (PVR)",
          "pulmonary vascular resistance (PVR) at baseline"
        ],
        [
          "Mean pulmonary arterial pressure (PAPm)",
          "mean pulmonary arterial pressure (mPAP) at baseline"
        ],
        [
          "Pulmonary Capillary Wedge Pressure (PCWP)",
          "pulmonary capillary wedge pressure (PCWP) at baseline"
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Male",
        "Region of Enrollment",
        "Weight",
        "Height",
        "N-terminal prohormone brain natriuretic peptide (NT-proBNP)",
        "Vasodilator testing during confirmatory right heart catheterization (RHC)?",
        "10 mmHg decrease in PAPm during Confirmatory RHC?",
        "Vasodilator medications used during Confirmatory RHC?"
      ],
      "remaining_candidate_features": [
        "ethnicity",
        "smoking history",
        "New York Heart Association (NYHA) functional class",
        "forced vital capacity (FVC) at baseline",
        "oxygen saturation at baseline",
        "use of chronic medications for underlying lung disease",
        "presence of connective tissue disease (CTD)"
      ]
    },
    "processed-gen-response": "Age, sex, race, ethnicity, body mass index (BMI), smoking history, New York Heart Association (NYHA) functional class, 6-minute walk distance (6MWD) at baseline, forced vital capacity (FVC) at baseline, pulmonary vascular resistance (PVR) at baseline, pulmonary capillary wedge pressure (PCWP) at baseline, mean pulmonary arterial pressure (mPAP) at baseline, oxygen saturation at baseline, use of chronic medications for underlying lung disease, presence of connective tissue disease (CTD)."
  }
}